Disseminated Mycobacterium massiliense skin infection in an immunocompromised patient requiring long-term treatment

J Dermatol. 2021 Apr;48(4):e201-e202. doi: 10.1111/1346-8138.15808. Epub 2021 Feb 13.

Authors

Maho Nishimura-Tagui¹, Koremasa Hayama¹, Hideki Fujita¹, Yuji Miyamoto², Norihisa Ishii³, Tadashi Terui¹

Affiliations

¹ Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
² Leprosy Research Center, National Institute of Infectious Diseases, Higashimurayama, Japan.
³ Leprosy Research Center, National Sanatorium Tamazenshoen, Higashimurayama, Japan.

PMID: 33580889
DOI: 10.1111/1346-8138.15808

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
Humans
Immunocompromised Host
Microbial Sensitivity Tests
Mycobacterium Infections* / diagnosis
Mycobacterium Infections* / drug therapy
Mycobacterium Infections, Nontuberculous* / diagnosis
Mycobacterium Infections, Nontuberculous* / drug therapy
Mycobacterium abscessus*

Substances

Anti-Bacterial Agents